In the US, the uncertainty comes from pessimism about the impossibility of cutting interest rates until the end of the first ...

Uranium spot prices remained volatile into the end of 2024 with ongoing cost pressures and geo-politics hanging over buyers, ...

ADELAIDE, South Australia and PERTH, Western Australia, Jan. 14, 2025 /PRNewswire/ -- Global Contract Development and ...

Hansen today partners with Community Solar developers across ten US states; primed to enter seven more as customer operations expand ...

Michael Gable of Fairmont Equities observes the multi-year downtrend for shares in Woodside Energy is no longer in place ...

MELBOURNE, Australia, Jan. 14, 2025 /PRNewswire/ — As Australia’s retail trading market matures, the focus is shifting beyond regulatory compliance to a broader culture of trader protection and ...

MELBOURNE, Australia and INDIANAPOLIS, Jan. 14, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today ...

Equities remain under the cloud of global bond markets with the yield on 10-year US Treasuries in the overnight trading ...

Joe Lowry, President Global Lithium, shares his insights on the status and the outlook for the lithium industry at large ...

Paul Greene, portfolio manager, US equities at T. Rowe Price, advocates investors should refine their approach to AI and ...

Kidney cancer therapy candidate, TLX250 (177Lu-girentuximab): The Company was granted a pre-investigational new drug (pre-IND) meeting with the U.S. Food and Drug Administration (FDA) in Q4 2024, to ...

MELBOURNE, Australia and LIÈGE, Belgium, Jan. 13, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TLX, Telix, the ...